The Union Health Ministry has clarified that there has been no change in the treatment plan for Tuberculosis treatment in India, countering misleading claims circulating on social media. Recent online posts suggested that the country had adopt...
Malaria’s impact on growth continues to be a critical concern for healthcare systems and emerging economies, particularly in regions where the disease remains endemic. The reality of slow progress becomes evident when evaluating how malaria...
A counterfeit medicine operation involving fake versions of Mounjaro has come under investigation in India after packaging errors exposed suspicious products circulating in the market. Authorities say the discovery highlights growing concern...
Biocon denosumab biosimilars have secured a major regulatory win, with Health Canada granting a Notice of Compliance (NOC) for two of the company’s products—Bosaya and Vevzuo—on April 3, 2026. The approval marks a significant step as Biocon...
The Government of India is stepping up efforts to strengthen healthcare infrastructure while focusing on the early diagnosis of non-communicable diseases (NCDs), Union Health Minister Jagat Prakash Nadda said during a recent policy discussion.
Bharat Parenterals Ltd said its subsidiary, Innoxel Lifesciences, has received five observations from the United States Food and Drug Administration (USFDA) following a recent USFDA inspection at its Vadodara facility.
India is set to take a major step toward improving end-of-life support as the Indian Council of Medical Research rolls out a palliative care study across multiple states. Announced today, this initiative aims to address a long-standing gap in the...
NCR’s fake Mounjaro problem is growing fast—and most people don’t see it coming. In fact, it is no longer limited to shady corners of the market. It’s now tied to a Rs 70 lakh cache of counterfeit injections recently uncovered, pointing to...
In a significant step toward transforming pediatric critical care, Aster CMI Hospital today announced the launch of PEARL (Pediatric Emergency and Advanced Response for Liver Care) – Karnataka’s first dedicated Pediatric Liver Intensive Care Unit...
OneSource Speciality Pharma has said that its partner, Orbicular Pharmaceutical Technologies, along with a US-based front-end partner, has received tentative approval from the U.S. Food and Drug Administration for a generic version of semaglutid...
.jpg)
, CDSCO.jpg)